drugset / Trial / NCT02037191

The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade

NCT02037191 ↗

Phase 3 Completed 90 enrolled University Hospital, Rouen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Alopecia areata (AA) is an auto immune disorder. Treatment of severe types remains difficult with a rate of hair regrowth which is lower than 10%. This RCT will assess the safety and efficacy of methotrexate alone or associated with low doses of prednisone versus placebo in the treatment of severe types of AA.

Timeline

Start
2014-02
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 25 mg —

Indications